Xenon Pharmaceuticals Insider Trades

XENE

Track insider trading activity from Xenon Pharmaceuticals executives and directors. See which insiders are buying and selling XENE stock.

Trades Last 12 Months

XENE Price

All Insider Trades for Xenon Pharmaceuticals

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kelly Thomas Patrick Chief Financial Officer
Holding Value $846k 22,500 shares
Last Trade
Oct 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$257k 7,500 shares
$34.33
$37.62
Mortimer Ian PRESIDENT & CEO
Holding Value $1.88M 49,923 shares
Last Trade
Sep 30, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.12M 30,000 shares
$37.38
$37.62
Svoronos Dawn Director
Holding Value $0 0 shares
Last Trade
Sep 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$309k 5,144 shares
$60.00
$37.62
Kenney Christopher John Chief Medical Officer
Holding Value $26.4k 702 shares
Last Trade
Aug 28, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$426k 7,068 shares
$60.25
$37.62
Gannon Steven Director
Holding Value $70.3k 1,870 shares
Last Trade
Aug 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$641k 10,000 shares
$64.06
$37.62
Cannon Gillian Director
Holding Value $54.7k 1,455 shares
Last Trade
Jun 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$63.2k 1,190 shares
$53.14
$37.62
Patou Gary Director
Holding Value $937k 24,896 shares
Last Trade
Jun 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$70.3k 1,322 shares
$53.14
$37.62
Holding Value $395k 10,507 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$647k 12,100 shares
$53.46
$37.62
Machado Patrick Director
Holding Value $395k 10,507 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$647k 12,100 shares
$53.46
$37.62
Gover Justin D. Director
Holding Value $395k 10,507 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$647k 12,100 shares
$53.46
$37.62
Gannon Steven Director
Holding Value $400k 10,641 shares
Last Trade
May 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$193k 3,500 shares
$55.00
$37.62
Di Fabio Andrea Chief Legal Officer
Holding Value $275k 7,301 shares
Last Trade
Mar 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$74.1k 1,342 shares
$55.23
$37.62
Kenney Christopher John Chief Medical Officer
Holding Value $266k 7,069 shares
Last Trade
Mar 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$77.9k 1,410 shares
$55.23
$37.62
Mortimer Ian PRESIDENT & CEO
Holding Value $750k 19,923 shares
Last Trade
Mar 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$404k 7,308 shares
$55.23
$37.62
Cline Darren S Chief Commercial Officer
Holding Value $1.5M 40,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.53M 60,000 shares
$42.15
$37.62
Patou Gary Director
Holding Value $640k 17,012 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$523k 17,012 shares
$30.73
$37.62
Holding Value $640k 17,012 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$523k 17,012 shares
$30.73
$37.62
Difabio Andrea Chief Legal Officer
Holding Value $3.01M 80,000 shares
Last Trade
Mar 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.84M 80,000 shares
$35.48
$37.62
Aulin Sherry Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Dec 18, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$771k 18,709 shares
$41.21
$37.62
Robin Sherrington Evp, Strategy & Innovation
Holding Value $2.45M 65,000 shares
Last Trade
Mar 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.88M 65,000 shares
$44.37
$37.62

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up